Skip to content
antibacterial .ai

Pipeline Pilot pricing: what BIOVIA Pipeline Pilot costs, from the public award record

BIOVIA publishes no price for Pipeline Pilot, and the per-user figures online cite nothing. Federal awards show what the server, the clients and the collections actually cost.

25 September 2026 8 min read Buying

Run a screen

of 3 left

Strain panel

No account needed. 3 screens per session.

Sample output Ciprofloxacin Fluoroquinolone
Worked example, replaced when you run
Strain MIC (µg/mL) Call Resistance risk Conf.
S. aureus (MRSA) 0.5->32 R Resistant target mutation, grlA and gyrA Fluoroquinolone resistance is widespread in methicillin resistant lineages.
E. coli <=0.015-0.06 S Susceptible efflux, AcrAB-TolC in resistant isolates Potent against wild type; qnr carriage and gyrA changes shift the band sharply.
K. pneumoniae (CRE) 0.5->64 R Resistant gyrA mutation with plasmid qnr Carbapenemase producing isolates almost always carry quinolone resistance too.
A. baumannii 8->64 R Resistant efflux, AdeABC Constitutive efflux plus target changes leave little room at achievable exposure.
P. aeruginosa 0.25-2 I Intermediate efflux, MexAB-OprM Borderline: active on many isolates, lost quickly once efflux is derepressed.
E. faecium (VRE) 4->32 R Resistant target mutation, parC Enterococci are intrinsically poor fluoroquinolone targets.

Why

Ciprofloxacin is a well characterised fluoroquinolone, so the Gram-negative bands are strongly supported by published activity data. The deciding factor across this panel is not target affinity but exposure: efflux in P. aeruginosa and A. baumannii, and acquired target mutation everywhere resistance is already common. Against a modern ESKAPE panel it reads as a Gram-negative agent with two reliable losses.

Closest published analogs

  • Levofloxacin Broadly similar Gram-negative bands, better Gram-positive coverage
  • Delafloxacin Retains activity against many ciprofloxacin resistant staphylococci
Strain MIC (µg/mL) Call Resistance risk Conf.

Why

Closest published analogs

Want the rest of your series? Batch runs are on the paid tiers. screen left in this session. This session is used up.

Computational prediction from published literature. Research use only, not a lab measurement and not clinical guidance.

Dassault Systemes does not publish a price for BIOVIA Pipeline Pilot, and it never has. The public record fills part of the gap: US federal agencies bought Pipeline Pilot directly from Accelrys for years, and those awards show a single add-on collection near $15,600, a server platform at $63,500 for a year, and full deployments of $188,890 to $202,606 across multi year terms. If you are budgeting Pipeline Pilot, plan on five figures for a narrow setup and six figures for anything a department will share.

That range is wide because Pipeline Pilot is not one product with one price. It is a server, a set of clients and a catalog of licensed collections, and the invoice is the sum of whichever of those you choose. Here is what the record shows, how the parts add up, and where the per-user figures circulating online come from.

How much does Pipeline Pilot cost?

On the public record, Pipeline Pilot costs from about $15,600 for a single collection to about $200,000 for a multi year deployment. The largest award, from the Department of Defense, is $202,606 for Pipeline Pilot Professional use running from September 2013 to November 2016. An earlier DoD award of $188,890 covers a base year license plus option years from 2011 to 2013. At the small end, NCATS paid $15,622 for a Data Modeling collection user for one year, and the FDA paid $17,500 for Pipeline Pilot software in 2010.

Term Agency What it covers Amount
Sep 2013 to Nov 2016 Department of Defense Pipeline Pilot Professional user $202,606
Feb 2011 to Nov 2013 Department of Defense Pipeline Pilot software license, base year plus options $188,890
Sep 2006 to Apr 2008 Department of Defense Implementation of Pipeline Pilot $100,000
Sep 2012 to Sep 2013 NIH (NCATS) Accelrys Enterprise Platform, license and service agreement $63,500
Aug 2010 FDA Pipeline Pilot software $17,500
Sep 2014 to Sep 2015 NIH (NCATS) Pipeline Pilot Data Modeling collection, user $15,622

Two cautions before these numbers go into a budget. They are government purchases, and a commercial biotech is quoted from a different sheet, so treat them as a floor and a shape rather than a forecast. And the direct awards stop in 2016. After Dassault bought Accelrys in 2014, BIOVIA software increasingly reached federal buyers through resellers whose award descriptions often do not name the product. One 2016 NCATS order for a Data Modeling collection went through a reseller called LabAnswer Government, and our BIOVIA Discovery Studio price breakdown shows the same reseller pattern across that product. Prices are older than they look, which argues for treating them as a minimum.

What you are actually paying for

Pipeline Pilot started life at SciTegic, which Accelrys acquired in 2004. Accelrys became part of Dassault Systemes in 2014 and was renamed BIOVIA. The architecture has stayed recognizable through all of it, and each layer is a line on the quote.

The server. Protocols run on a Pipeline Pilot server, which in the Accelrys years was sold as the Accelrys Enterprise Platform. The NCATS award at $63,500 for one year is exactly that: a platform license and service agreement, bought before any user did anything with it. Everything else on the quote runs on top of it, so it is the line to settle first.

The clients. Scientists build workflows in the Pipeline Pilot Professional Client, and colleagues who only run finished protocols can use them through a browser, which BIOVIA calls Web Port. The DoD award for "Pipeline Pilot Professional user" is the authoring side. Because authoring and running are different jobs, the usual way to keep a quote down is to license a few authors and let everyone else run what they build.

The collections. Collections are the domain packs that give Pipeline Pilot something to say about chemistry, biology or images. The named list is long: Chemistry, ADMET, Data Modeling, Advanced Data Modeling, Imaging, Next Generation Sequencing, Reporting, Integration, Chemical Text Mining, Plate Data Analytics and more. Each is licensed on top of the server, which is why the NCATS Data Modeling collection appears as its own award at $15,622. A quote with six collections and a quote with two are different purchases.

Where the "$5,000 per user" figures come from

Search for Pipeline Pilot pricing and you will see software listing sites quoting per-user annual figures, sometimes a few hundred dollars a month, sometimes a round $5,000 a year. None of them cite a source we could read, and none separate the server, the clients and the collections, which is how the product is actually sold. We would not put those figures in a budget. A per-user number with no server attached describes a product Pipeline Pilot is not.

The federal awards are better evidence for one simple reason: somebody signed them. They are also older and government priced, so the honest position is that nobody outside BIOVIA's sales team has a current commercial list, and anyone who claims to is guessing.

Is Pipeline Pilot worth the price?

For the right organization, yes. Pipeline Pilot earns its cost where many teams need the same data handled the same way every time: registration pipelines, assay data processing, plate analytics, model scoring against a whole compound collection, reports that run on a schedule. It gives scientists a visual way to build those workflows and gives IT a server that runs them under control, and large pharma has leaned on it for exactly that for two decades. If you already run BIOVIA software, the integration with the rest of the stack is a real advantage.

It is harder to justify for a small team. A lot of what Pipeline Pilot protocols do in practice is plumbing: pulling records from one system, reshaping them and pushing them into another. If that is most of your need and the chemistry is incidental, you may be buying a scientific platform to do a general data integration job between your apps and databases, which is a smaller and cheaper category. And if you have no one who wants to author protocols, the license will sit on a server doing very little.

What are the alternatives to Pipeline Pilot?

The alternatives split by what you are using Pipeline Pilot for. For visual workflow building, KNIME is the common choice: the desktop Analytics Platform is open source and there is a commercial server tier for scheduling and sharing. For cheminformatics code, RDKit covers much of what the Chemistry collection does, provided someone on the team writes Python. For modeling, the commercial suites are priced very differently, and we have broken them down from the same kind of evidence in MOE software price and OpenEye Scientific Software price.

None of those alternatives answer the question many antibacterial teams actually bought Pipeline Pilot to automate, which is scoring a compound set for likely activity against specific organisms. A workflow can run a model; it cannot supply one. You still need an antibacterial model trained on MIC data you probably do not have.

A narrower purchase, if the question is narrow

Plenty of AMR groups price a workflow platform when the recurring job is much smaller: which compounds in this library are worth plate time, against which pathogens. That job does not need a server, a client and a collection. Paste a structure or a peptide sequence into the tool above and a predicted MIC band comes back for each organism in the panel, with an S, I or R call, the resistance mechanism expected to limit it, and a confidence level on every row. Lab is $149 a month, or $1,788 across a year, which is less than the smallest Pipeline Pilot award in the record.

If the reason you wanted Pipeline Pilot was to run that scoring inside your own pipeline, Discovery at $499 a month includes the REST API, so the same predictions drop into whatever orchestration you already have. The details are on antibacterial screening API, library triage at scale is covered on compound library screening software, and the category-wide view of who publishes prices is on drug discovery software cost.

From the note to a read-out

Screen the compound this note made you think about. Three screens per session, no account, and the full matrix every time.

Run a screen first

What you are agreeing to

  • Your compounds stay yours
  • Never used for model training
  • Deletable on request
  • No card needed to create your account

Screen your own compound.
No card required.